PCVX

Vaxcyte Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↓ 0/10
  • Value↑ 5/10
Vaxcyte sales and earnings growth
PCVX Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -72.43%
  • FCF Y/Y↓ -37.28%
Vaxcyte gross and profit margin trends
PCVX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -34.71%
Vaxcyte net debt vs free cash flow
PCVX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vaxcyte stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks